New Website Broadcasts Urgent Need for Lupus Clinical Trials

Will Next Decade Be 'Golden Era' of Lupus Drug Development?

No New FDA-Approved Drugs to Treat the Disease in 40+ Years

May 21, 2007 (New York, NY) – The Lupus Research Institute and its National Coalition of state and local lupus organizations today announced the launch of, the official website for the new clinical trials campaign “Lupus Together: For Clinical Trials Today.”

The patient-friendly site is part of a year-long national initiative to educate the more than 1.5 million Americans with lupus—a chronic autoimmune disease for which there is no known cause, few medicines, and no cure—about the importance of participating in lupus clinical trials, and how to go about enrolling in one.

The timing is critical, as promising new research findings spur drug developers to contemplate clinical research in lupus for the first time in decades.

Of the more than 15 clinical trials underway, many explore alternatives to the presently used drugs that are often as destructive—or even more so—than the disease itself. Currently approved therapies for lupus can weaken bones, destroy eyesight, cause uncontrollable appetite and mood swings, and sharply increase the risk for infection, diabetes and infertility, among other insidious and potentially life-threatening complications.

“Our patients need better treatment options,” explains Margaret Dowd, president of the Lupus Research Institute. “Now is the time for the next generation of lupus therapies. We have waited long enough.”

To spread awareness of the existence and promise of clinical trials, visitors to the new website will not only learn about the clinical trial process but can read first-hand accounts of others who have participated in trials and get strategies for locating a trial that is taking place close to them.

“Our hope is that the next 10 years will be the Golden Age for the development of new lupus drugs,” says leading lupus doctor Richard Furie, MD, chief of rheumatology at North Shore-LIJ Health System in New York. “Science is ready. But for success, the lupus community must band together.”

We have the experts to conduct the trials. We have the Institute and others to get the word out. But to get results, we need lupus patients to show interest. This is for them. They need to do their part.”

Without enough study volunteers, trials cannot successfully determine the effectiveness of a treatment. This may discourage companies from exploring new drugs for lupus in the future.

To learn more about lupus clinical trials, log on to

The “Lupus Together: For Clinical Trials Today” is a campaign of the Lupus Research Institute National Coalition and is supported in part by unrestricted educational grants from Aspreva Pharmaceuticals, Genentech/Biogen Idec., and creative support from the New Jersey-based advertising agency, Galvanek & Wahl.

About Lupus:
Lupus is one of America's least recognized major diseases. It is estimated that as many as 2 million Americans have lupus. Systemic lupus erythematosus (S.L.E.), commonly called lupus, is a chronic and potentially fatal autoimmune disorder. It is considered the prototype autoimmune disease because the body’s immune system forms antibodies that can attack virtually any healthy organ or tissue, from the kidneys to the brain, heart, lungs, skin, joints and blood. No major new treatments for lupus have been approved in the last 40 years, and existing medications are highly toxic and can have debilitating effects.

About the Lupus Research Institute:
Pioneering Discovery to prevent, treat and cure lupus. The Lupus Research Institute (LRI), the country’s only nonprofit organization singularly devoted to novel research in lupus, champions innovation, encourages scientific creativity and risks exploring uncharted territory to bring new scientific solutions to the complex and dangerous autoimmune disease of lupus.  Founded by families and shaped by scientists, the Institute mandates sound science and rigorous peer review to uncover and support only the highest ranked novel research. Its bold and proven research strategy places the LRI at the forefront of lupus science as the Institute consistently achieves the breakthrough discoveries, novel insights and solid results that are changing the course of lupus research and bringing new hope to people with lupus nationwide.

To learn more about lupus and the Lupus Research Institute, visit